GlassScriptPhysician profile
Amanda Willis Bailey
NPI 1326453895
$1,142.10
in general payments reported to CMS, 2019-2025
12 companies · $695 in 2025
The $695 reported for 2025 was more than what 95% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $20.03 · 2023: $201 · 2024: $106 · 2025: $695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $672 · Food and Beverage: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $672.00 |
| Food and Beverage | $330.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $672.00 | 2025 | |
| Corium, LLC | $152.73 | 2023 | Azstarys |
| Amgen INC. | $107.78 | 2021 | |
| Neurelis, INC. | $37.12 | 2024 | Valtoco |
| Sanofi-Aventis U.S. LLC | $35.12 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $25.61 | 2023 | |
| Glaxosmithkline, LLC. | $23.43 | 2025 | Rotarix, Bexsero |
| Ironshore Pharmaceuticals INC. | $23.04 | 2023 | Jornay Pm |
| Astrazeneca Pharmaceuticals LP | $20.66 | 2024 | Flumist Quadrivalent |
| Hologic Sales and Service, LLC | $20.03 | 2022 | |
| Aytu Biopharma, INC. | $13.10 | 2024 | Karbinal |
| Pfizer INC. | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.